Page 90 - 《中国药房》2023年19期

29-38. tree model based on randomized controlled trial[J]. J
[16] 王卓珏，李元霞，庞随军. 阿奇霉素联合口服中成药治疗 Altern Complement Med，2019，25（12）：1183-1192.
儿童支原体肺炎的 Meta 分析及药物经济学评价[J]. 中 [24] LIU G，HUANG Z Y，XIN Q. Cost-effectiveness of oral
国药物经济学，2022，17（7）：25-30，38. antidiabetic drugs：a prospective multicenter study of real-
WANG Z J， LI Y X， PANG S J. Meta analysis and phar‐ world patients[J]. Evid Based Complement Alternat Med，
macoeconomic evaluation of azithromycin combined with 2021，2021：9972386.
oral Chinese patent medicine in the treatment of Myco‐ [25] XUAN J W，HUANG M，LU Y J，et al. Economic evalua‐
plasma pneumonia in children[J]. China J Pharm Econ， tion of Safflower yellow injection for the treatment of pa‐
2022，17（7）：25-30，38. tients with stable angina pectoris in China：a cost-
[17] 刘峘，崔鑫，谢雁鸣，等. 香菊胶囊治疗慢性鼻-鼻窦炎的 effectiveness analysis[J]. J Altern Complement Med，
药物经济学评价[J]. 中国中药杂志，2022，47（14）：3950- 2018，24（6）：564-569.
3955. [26] YU X Q，YANG S G，LI H，et al. Preliminary study to
LIU H， CUI X， XIE Y M， et al. Pharmacoeconomic evaluate three different treatments on stable chronic ob‐
evaluation of Xiangju capsules in treatment of chronic rhi‐ structive pulmonary disease patients based on Markov
nosinusitis[J]. China J Chin Mater Med，2022，47（14）： model[J]. Evid Based Complement Alternat Med，2019，
3950-3955. 2019：6478926.
[18] 周黎，项予良，郭昭婷，等. 银杏内酯注射液对比丁苯酞 [27] LU L，LI Y，JIN Q C，et al. Safflor yellow treating angina
注射液治疗大动脉粥样硬化性缺血性脑卒中的最小成 pectoris：a pharmacoeconomic evaluation and network
本分析[J]. 中国药房，2020，31（18）：2235-2239. meta-analysis[J]. Medicine，2022，101（41）：e31036.
ZHOU L，XIANG Y L，GUO Z T，et al. Cost-minimization [28] LI Y，LIN Y，SHI Z X，et al. Safflower yellow pigment
analysis of Ginkgolide injection versus Butylphthalide in‐ and Sanqi Panax notoginseng in the treatment of acute ce‐
jection in the treatment of ischaemic stroke of large-artery rebral infarction：a systematic review，meta-analysis，and
atherosclerosis[J]. China Pharm，2020，31（18）：2235- cost-effectiveness analysis[J]. Ann Transl Med，2021，9
2239. （18）：1407.
[19] 唐显帅，郑磊，张明珠，等. 基于循证医学证据和药物经 [29] XU Q，YANG N，FENG S，et al. Cost-effectiveness analy‐
济学模型的中成药临床综合评价[J]. 中国药房，2022，33 sis of combining traditional Chinese medicine in the treat‐
（15）：1870-1875. ment of hypertension：compound Apocynum tablets com‐
TANG X S，ZHENG L，ZHANG M Z，et al. Clinical com‐ bined with Nifedipine sustained-release tablets vs Nifedi-
prehensive evaluation for Chinese patent medicine based pine sustained-release tablets alone[J]. BMC Complement
on evidence-based medicine and pharmacoeconomic Med Ther，2020，20（1）：330.
model[J]. China Pharm，2022，33（15）：1870-1875. [30] SONG Z，SUN L Y，GU S S，et al. Exploring the safety，
[20] XIANG Y L，YANG N，GUO Z T，et al. Cost- effectiveness，and cost-effectiveness of a Chinese patent
effectiveness analysis of Ginkgolide injection in the treat‐ medicine （Fufang e’jiao syrup） for alleviating cancer-
ment of ischemic stroke based on a randomized clinical related fatigue：a protocol for a randomized，double-
trial[J]. J Altern Complement Med，2021，27（4）：331-341. blinded，placebo-controlled，multicenter trial[J]. Integr
[21] HU M，DING P，MA J F，et al. Cost-effectiveness analysis Cancer Ther，2021，20：15347354211002919.
of the TCM “Yupingfeng granules” in the treatment of [31] DRUMMOND M F，SCULPHER M J，CLAXTON K，
acute exacerbations of COPD based on a randomized clini‐ et al. Methods for the economic evaluation of healthcare
cal trial[J]. Int J Chron Obstruct Pulmon Dis，2022，17： programs[M]. Fourth edition. Oxford：Oxford University
2369-2379. Press，2015：1-396.
[22] SHI H H，GUO W J，ZHU H，et al. Cost-effectiveness [32] 陈昌明，刘杰，张英，等 . 晚期非小细胞肺癌患者三种治
analysis of Xiyanping injection （andrographolide sulfo‐ 疗方案经济学评价[J].中国中医基础医学杂志，2018，24
nate） for treatment of adult community acquired pneumo‐ （4）：507-509，529.
nia：a retrospective，propensity score-matched cohort study CHEN C M，LIU J，ZHANG Y，et al. Economic evalua‐
[J]. Evid Based Complement Alternat Med，2019，2019： tion of three treatment regimens for advanced non-small
4510591. cell lung cancer[J]. Chin J Basic Med Tradit Chin Med，
[23] ZHOU J，LIU F，JIANG W L，et al. Cost-effectiveness of 2018，24（4）：507-509，529.
Jingshu granules compared to placebo for the treatment of （收稿日期：2023-03-30 修回日期：2023-09-07）
patients with cervical radiculopathy in China：a decision- （编辑：胡晓霖）

· 2384 · China Pharmacy 2023 Vol. 34 No. 19 中国药房 2023年第34卷第19期